MSC (MSM)
(Delayed Data from NYSE)
$86.26 USD
+2.52 (3.01%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $86.26 0.00 (0.00%) 5:20 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.26 USD
+2.52 (3.01%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $86.26 0.00 (0.00%) 5:20 PM ET
4-Sell of 5 4
B Value A Growth B Momentum A VGM
Zacks News
MSC Industrial (MSM) Q3 Earnings Match Estimates
by Zacks Equity Research
MSC Industrial (MSM) delivered earnings and revenue surprises of 0.00% and -0.45%, respectively, for the quarter ended May 2018. Do the numbers hold clues to what lies ahead for the stock?
Cimpress Rides on Portfolio Restructuring, Risks Persist
by Zacks Equity Research
Cimpress' (CMPR) business is scalable and its web presence and online tools for customer use are well established, although foreign currency woes remain potential headwinds.
Here's Why You Should Buy MSC Industrial (MSM) Stock Now
by Zacks Equity Research
MSC Industrial Direct (MSM) is well poised to gain from better operating conditions in the industry and synergistic benefits from acquired assets. Rewarding shareholders handsomely remains a priority.
Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv
Best Five Momentum Stocks for January 2017
by David Bartosiak
Kick off the New Year with the best five momentum stocks to buy
Stocks Most Likely to Beat Earnings for the Week of January 9th
by Zacks Equity Research
Here are four stocks that are likely to beat earnings for the week of December 9th: